Patient-Reported Outcomes in Children With Chronic Kidney Disease

Leonela Villegas1, Sandra Amaral2

  • 1Division of Nephrology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.

Seminars in Nephrology
|December 17, 2021
PubMed

Insights

Patient-reported outcomes (PROs) offer valuable insights into the health of children with chronic kidney disease (CKD). This review explores PRO development and implementation to improve care for pediatric CKD patients.

Area of Science:

  • Nephrology
  • Pediatrics
  • Health Outcomes Research

Background:

  • Patient-reported outcomes (PROs) capture patient perspectives on health, distinct from clinician assessments.
  • PROs are crucial for understanding the daily experiences of children with chronic kidney disease (CKD).
  • PROs address a gap in optimizing health and well-being for pediatric CKD populations.

Purpose of the Study:

  • To review the development and implementation of PROs for children with CKD.
  • To identify knowledge gaps in clinical and research applications of PROs for pediatric CKD.
  • To highlight future directions and challenges in PRO utilization for this population.

Main Methods:

  • Literature review of PRO development.
  • Analysis of PRO implementation strategies in pediatric CKD.
  • Synthesis of current challenges and future research avenues.

Main Results:

  • PROs provide unique insights into the lived experiences of children with CKD.
  • Existing PROs may not fully capture all relevant domains for pediatric CKD.
  • Knowledge gaps exist in the widespread clinical and research application of PROs.

Conclusions:

  • PROs are essential for comprehensive care and research in pediatric CKD.
  • Further research is needed to refine PRO development and implementation for children with CKD.
  • Addressing implementation challenges is key to maximizing the benefits of PROs in pediatric nephrology.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
102
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
80
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
143
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
128
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
165
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
16